Several trials have provided essential evidence for COVID-19 therapies. Based on the most recent updates, the Infectious Diseases Society of America (IDSA) guideline panel has issued 32 recommendations regarding the treatment and management of COVID-19 patients belonging to the following categories: patients hospitalized with mild-to-moderate, severe but not critical, and critical disease. Click here to view the infographic! Would you to like to gain detailed insights into the IDSA guideline and its recommendations?
Stay tuned for the part of this IDSA guideline . It will focus on the drugs. Do you think the IDSA guidelines will be helpful for patients affected by new COVID-19 strains? Suggested for you COVID-19 Treatment and Management: IDSA Guidelines (2022) COVID-19 Guidelines on Inhaled Corticosteroids: IDSA 2022 COVID-19 and MIS-C Treatment Guidelines for Pediatric…
